SNY
SanofiNASDAQHealthcare$47.89+0.34%OpenMarket Cap: $116.63B
As of 2026-04-06
Valuation
P/E (TTM)
14.93
PEG
0.37
P/B
1.41
P/S
1.71
EV/EBITDA
10.25
DCF Value
$137.32
FCF Yield
19.0%
Div Yield
4.7%
Margins & Returns
Gross Margin
71.7%
Operating Margin
25.4%
Net Margin
18.2%
ROE
14.7%
ROA
17.9%
ROIC
11.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $12.21B | 70.3% | $-1.04B | $-801.0M | $-1.46 | — |
| FY 2025 | $46.72B | 72.3% | $6.34B | $7.81B | $2.03 | $2.21 |
| Q3 2025 | $13.17B | 74.1% | $3.62B | $2.80B | $1.14 | — |
| Q2 2025 | $10.73B | 72.1% | $1.47B | $3.94B | $1.60 | $2.21 |
| Q1 2025 | $10.61B | 72.8% | $2.29B | $1.87B | $0.76 | — |
| Q4 2024 | $7.63B | 70.2% | $573.0M | $499.0M | $0.35 | — |
| FY 2024 | $44.29B | 70.2% | $7.25B | $5.56B | $2.19 | $2.04 |
| Q3 2024 | $14.16B | 71.1% | $3.63B | $2.81B | $1.13 | — |
| Q2 2024 | $11.38B | 70.0% | $1.59B | $1.11B | $0.45 | $2.04 |
| Q1 2024 | $9.73B | 69.5% | $1.24B | $1.13B | $0.46 | — |
| Q4 2023 | $12.20B | 66.8% | $342.0M | $-555.0M | $-0.22 | — |
| FY 2023 | $41.62B | 69.7% | $6.96B | $5.40B | $2.15 | $1.90 |